Literature DB >> 15149515

Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens.

J Wenzel1, R Gerdsen, M Uerlich, R Bauer, T Tueting, T Bieber.   

Abstract

BACKGROUND: Leukopenia and lymphopenia are typical features of lupus erythematosus (LE) and correlate with elevated disease activity and higher grades of systemic involvement. Antilymphocyte antibodies are regarded as the most likely rationale for the decreased cell numbers; however, their relevance has not been confirmed so far.
OBJECTIVES: Previous investigations at our department have shown a significant correlation between diminished lymphocyte numbers and the presence of antinuclear antibodies (ANA). We wanted to achieve a better understanding of this phenomenon.
METHODS: We performed a detailed analysis of autoantibodies and peripheral leucocyte subsets in 82 patients with different subtypes of LE. Leucocyte subsets were measured using flow cytometry (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA.); autoantibodies were detected by indirect immunofluorescence and by enzyme-linked immunosorbent assay.
RESULTS: A significant association (P < 0.05) between specific antibodies targeting nuclear antigens (SSA/Ro-52, SSB/La, snRNPs) and lymphocytopenia was found.
CONCLUSIONS: We suppose that some of these autoantibodies might have an antilymphocyte effect. Apoptosis induction by specific antinuclear antibodies has already been described earlier, but to the best of our knowledge this is the first study presenting a strong indication of a possible interaction between these antibodies and lymphocyte subsets in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149515     DOI: 10.1111/j.1365-2133.2004.05848.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia.

Authors:  Y Yuan; H Ma; Z Ye; W Jing; Z Jiang
Journal:  Z Rheumatol       Date:  2018-04       Impact factor: 1.372

2.  The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.

Authors:  John V Asimakopoulos; Evangelos Terpos; Loula Papageorgiou; Olga Kampouropoulou; Dimitris Christoulas; Anastasios Giakoumis; Michael Samarkos; George Vaiopoulos; Konstantinos Konstantopoulos; Maria K Angelopoulou; Theodoros P Vassilakopoulos; John Meletis
Journal:  Med Sci Monit       Date:  2014-01-27

Review 3.  Haematological manifestations of lupus.

Authors:  Anum Fayyaz; Ann Igoe; Biji T Kurien; Debashish Danda; Judith A James; Haraldine A Stafford; R Hal Scofield
Journal:  Lupus Sci Med       Date:  2015-03-03

4.  [Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study].

Authors:  Fatima Zahra Ha-ou-nou; Lamiaa Essaadouni
Journal:  Pan Afr Med J       Date:  2015-05-04

5.  Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.

Authors:  Aurora Menéndez; Jesús Gómez; Luis Caminal-Montero; José Bernardino Díaz-López; Iván Cabezas-Rodríguez; Lourdes Mozo
Journal:  ScientificWorldJournal       Date:  2013-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.